Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0086 USD | 0.00% | 0.00% | -95.41% |
Mar. 05 | Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc.. | CI |
Feb. 16 | Peak Bio, Inc. announced that it has received $2.238 million in funding | CI |
Financials (USD)
Sales 2021 | 0.53 | Sales 2022 | 0.61 | Capitalization | 84.05M |
---|---|---|---|---|---|
Net income 2021 | -8M | Net income 2022 | -13M | EV / Sales 2021 | - |
Net Debt 2021 | 1.29M | Net Debt 2022 | 7.83M | EV / Sales 2022 | 151,191,556 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-5.67
x | Employees | 21 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.94% |
Current month | +1.18% | ||
1 month | +65.38% | ||
3 months | -77.19% | ||
6 months | -89.24% | ||
Current year | -95.41% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen LaMond
CEO | Chief Executive Officer | - | 22-10-31 |
Director of Finance/CFO | 62 | 22-10-31 | |
Satyajit Mitra
BRD | Director/Board Member | 50 | 22-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Neal
BRD | Director/Board Member | 68 | 22-10-31 |
Ho Young Huh
CHM | Chairman | 54 | 22-10-31 |
Michael Friedman
BRD | Director/Board Member | - | 23-08-24 |
1st Jan change | Capi. | |
---|---|---|
-95.41% | 195K | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+28.31% | 12.16B | |
+24.73% | 12.17B |
- Stock Market
- Equities
- PKBO Stock